Pelthos Therapeutics – 13-11-2025

In its May press release, HHS also advised that it will calculate the MFN price as the lowest price in a country that is part of the Organisation for Economic Co-operation and Development and that has a per capita gross domestic product (“GDP”) of at least 60% of the U.S. per capita GDP. The Company will continue to evaluate the 2025 EO and its potential impact to international opportunities for ZELSUVMI.

Scroll to Top